Home > Back to Publisher > Report Information

Commercial Opportunities for Enzyme Technologies (3rd Edition)

Drug and Market Development Publishing
November 1, 2006
302 Pages - SKU: DSMD1373636

Abstract Table of Contents Search inside this report Related Reports

D&MD’s Commercial Opportunities in Enzyme Technologies, 3rd Edition examines the many current opportunities for enzymes as well as areas targeted for future growth. Specific attention is paid to the growing and various uses of enzymes over several industries from industrial uses to therapeutic targets. In addition, this Report profiles companies designing and producing enzymes, detailing their technologies and product pipelines.

D&MD Publications is a leading provider of quality market analysis, opportunity assessment and tactical guidance filling the ever-changing needs of the life sciences market. For nearly two decades, D&MD products have been prepared by experts using industry interviews and case studies as well as gathering crucial information for decision makers within the pharmaceutical, biotechnology, medical device, and diagnostics sectors.

CHAPTER 1: EXECUTIVE SUMMARY
CHAPTER 2: INTRODUCTION
CHAPTER 3: FOUNDATIONS: Formal Classification Groups for Enzymes; Enzyme Assays
CHAPTER 4: ENZYME ENGINEERING: Source Organisms; Strategies for Developing Diversity Libraries; Other Sources of Diversity; Engineering Goals; Engineering Methods; Screening; Format and Purification
CHAPTER 5: ENZYMES AS COMMERCIAL PRODUCTS: Market Demand for Enzymes; Detergent Additives; Food Additives and Food Processing; Enzymes for Feed Supplementation; Pharmaceuticals; Research and Development Products; Clinical Assays
CHAPTER 6: ENZYMES AS THERAPY TARGETS: Enzyme Target Families
CHAPTER 7: POTENTIAL GROWTH AREAS FOR ENZYMES: Pharmaceutical Processing; Solid Phase Enzyme Chemistry; Specialty Chemical Applications; Biopulping; Waste Remediation; Biosensors; Biofilm Control; Energy Substitution—Ethanol
CHAPTER 8: COMPANY PROFILES: Altus Pharmaceuticals; Biocon; BioResearch Ireland; Chimerix; DIREVO Biotech; Diversa; GE Healthcare; Genencor; Hoffmann-La Roche; Invitrogen; Kikkoman; Maxygen; Novo Nordisk; Toyobo; Xencor
TABLE OF EXHIBITS: Exhibit 2.1 Industrial Enzymes Companies; Exhibit 2.2 Enzyme Evolution Companies; Exhibit 2.3 Pulp and Paper and Remediation Companies; Exhibit 2.4 Feed Enzymes Companies; Exhibit 2.5 Companies Marketing Laboratory Enzymes; Exhibit 2.6 Companies Working on Fine Chemicals; Exhibit 3.1 Enzyme Reaction Kinetic Equation; Exhibit 3.2 Michaelis-Menten Equation; Exhibit 3.3 Lineweaver-Burk Equation; Exhibit 3.4 Eadie-Hoftsee Equation; Exhibit 3.5 Examples of Kinetic Constants for Particularly Fast Enzymes; Exhibit 3.6 Examples of Enzymes Requiring Inorganic Cofactors; Exhibit 3.7 Examples of Inborn Errors of Metabolism and Enzyme Deficiencies; Exhibit 3.8 Formal Enzyme Classification System; Exhibit 3.9 Nomenclature of Some Industrially Important Enzymes; Exhibit 3.10 Endopeptidase (Proteinase) Subclasses; Exhibit 4.1 Extremophiles and Their Environments; Exhibit 4.2 Extremophiles and Their Uses in Biotechnology; Exhibit 4.3 Thermophilic DNA Polymerases; Exhibit 4.4 Conditions under which Laundry Proteases Perform; Exhibit 4.5 Effects of Detergent Components on Proteases; Exhibit 5.1 Enzyme Markets and Trends; Exhibit 5.2 Common Detergent Proteinases; Exhibit 5.3 Food and Feed Enzymes from Naturally Occurring Sources; Exhibit 5.4 FDA Approved Enzymes; Exhibit 5.5 Target Sequences of a Few New Restriction Endonucleases; Exhibit 6.1 Enzyme Targeted Drug Candidate Activity; Exhibit 6.2 Launched and Late Phase Drugs

Commercial Opportunities for Enzyme Technologies (3rd Edition)

Share this report

Other tasks

Research Assistance

Related Markets

Research & Development Reports

Free Alert Me service